OneLeaf, a Paris-based health startup, raised a $5.1M Seed round in 2024 to bring self-hypnosis to the mass market. The 13-slide deck focuses heavily on destigmatizing hypnosis by citing clinical studies and positioning it as 'the new mindfulness.' By highlighting specific pain points—such as the $150 cost of traditional hypnotherapy and the lack of trusted brands—OneLeaf builds a case for a scalable digital alternative. The deck is notable for its early conversion metrics, reporting a 48% sign-up rate and a 21% payment conversion within seven days. While the deck lacks a formal team slide or…
Key takeaways
- The deck addresses the high barrier to entry for traditional hypnotherapy, citing a cost of approximately $150 per session on Slide 2.
- OneLeaf positions self-hypnosis as a scientifically backed alternative, citing a 72% improvement in pain scores for HIV neuropathic pain patients on Slide 4.
- The company targets a massive total addressable market by listing 18 distinct use cases, ranging from sleep to early ejaculation, on Slide 6.
- A dual revenue model is proposed on Slide 9, offering users a choice between a one-time fee per program or an annual subscription.
- Initial go-to-market testing in the US resulted in a 48% sign-up conversion rate, as reported on Slide 11.
- The deck identifies a specific SEO opportunity for market entry, noting over 80,000 monthly SEM/SEO requests for smoking cessation on Slide 11.
- Clinical validation is a core pillar of the pitch, with an appendix dedicated to five distinct medical studies on Slide 13.
- OneLeaf raised $5.1M in a 2024 Seed round according to publisher-reported facts from Business Insider.
OneLeaf: Destigmatizing Hypnosis for the Mass Market
OneLeaf’s 13-slide deck is a masterclass in category creation. Hypnosis often carries a 'stage-magic' stigma, which can be a significant hurdle for investors. OneLeaf counters this by leaning heavily into clinical data and comparative positioning. By calling hypnosis 'the new mindfulness,' they attempt to draft off the multi-billion dollar success of apps like Calm and Headspace while offering a more 'active' therapeutic intervention.
Slide 1-3: The Brand and the Friction
The deck opens with a minimalist title slide featuring a monstera leaf, setting a calm, wellness-oriented tone. Slide 2 immediately dives into the Problem . It identifies three core friction points: the difficulty of breaking habits alone, the fear/misunderstanding of hypnosis, and the high cost of professional sessions. By quoting a price of $150 per session on Slide 2, OneLeaf establishes a clear value proposition for a lower-cost digital alternative. The mention of a lack of 'worldwide brands you can trust' in the hypnotherapy space signals their ambition to become the category leader.
Slide 4-5: Scientific Validation as a Product Feature
Slide 4, titled 'What is it and Why it works?', is the most critical slide for a company in this sector. It defines self-hypnosis as a method to access the unconscious mind. To move past the 'woo-woo' perception, the slide includes two heavy-hitting statistics: 72% of patients with HIV neuropathic pain reported improved scores, and 54% of IBS patients experienced long-term relief. These are not general wellness claims; they are specific medical outcomes cited from ResearchGate. This framing shifts the conversation from 'relaxation' to 'clinical efficacy.'
Slide 6-8: The Scale of the Opportunity
Slide 6, titled Ultra-Scalable , lists 18 different use cases for the platform. This list is exhaustive, covering everything from Weight Loss and Quit Smoking to more niche areas like Early Ejaculation and Libido . While investors often prefer a narrow focus, this slide serves to show the massive ceiling for the technology. If the core audio delivery mechanism works for one habit, it can theoretically work for all of them. The visual of 'reaching billions' reinforces the venture-scale potential of what might otherwise look like a niche app.
Slide 9-10: The Business Model Flywheel
The Business Model on Slide 9 is presented as a three-step cycle. It offers a one-time fee per program or an annual subscription . This is a smart tactical move for a habit-breaking app. Many users may only want to 'quit smoking' and might be hesitant to sign up for a recurring subscription. By offering a one-time fee, OneLeaf lowers the barrier to entry, then uses the 'results' (Step 2) to drive the user toward an annual subscription for other problems (Step 3). It is a 'land and expand' strategy applied to personal health.
Slide 11: Go-to-Market and Early Traction
Slide 11 provides the 'proof in the pudding.' OneLeaf reveals its 2022 US market entry strategy, focusing on smoking and weight loss. The data here is compelling: a 48% Sign-Up Conversion Rate and a 21% payment conversion within seven days. These are high-performance metrics for any consumer app. The slide also notes that there are 80,000 SEM/SEO requests per month for quitting smoking, justifying their choice of entry point with hard search volume data. This slide proves that the team isn't just building a product; they are building a customer acquisition engine.
Slide 12-13: The Scientific Appendix
The deck concludes with an Appendix dedicated to scientific studies. Slide 13 lists five specific medical applications of self-hypnosis, including a 68% decrease in hot flashes for breast cancer survivors and improved empowerment for women in labor. Ending on science rather than a 'thank you' slide reinforces the company's commitment to being a health-first, rather than a wellness-first, organization.
What Works in the OneLeaf Deck
Clinical Anchoring: By citing specific percentages from medical journals (72%, 54%, 68%), OneLeaf bypasses the skepticism usually associated with hypnosis. · Clear Pricing Comparison: Contrasting a digital app against a $150-per-hour human therapist makes the ROI for the consumer immediately obvious. · High-Intent GTM: Focusing on smoking cessation—a high-intent, high-pain problem with significant search volume—is a much stronger entry point than 'general wellness.' · Conversion Transparency: Sharing the 21% payment conversion rate gives investors confidence in the unit economics and user motivation.
What is Missing from the OneLeaf Deck
The Team Slide: In the provided 13-slide sequence, there is no mention of the founders or their backgrounds. For a $5.1M Seed round, the 'who' is usually as important as the 'what,' especially in a regulated field like healthcare. · Competitive Landscape: While they mention 'low/zero competition' for smoking on Slide 11, they don't address indirect competitors like Calm, Headspace, or pharmaceutical aids (nicotine patches, etc.). · Financial Projections: There is no slide detailing how the $5.1M will be spent or what the revenue targets are for the next 18-24 months. · Product UX: We see lifestyle photography, but we don't see the actual interface of the app. Investors usually want to see the 'magic' of the user experience.
Founder Takeaways: What to Copy
The 'New X' Framing: Positioning hypnosis as 'the new mindfulness' (Slide 4) is a brilliant way to explain a complex or misunderstood product by relating it to a known, successful category. · The Flywheel Model: If your product solves a specific 'one-off' problem, copy the Slide 9 approach of offering a per-use fee that leads into a subscription. It reduces friction for the first sale. · Data-Driven GTM: Don't just say you are launching in a market; explain why using search volume (80,000 requests) and success rates (8% success for solo quitters), as seen on Slide 11. · Appendix for Credibility: If your industry is controversial or niche, move the heavy reading to an appendix. It keeps the main narrative fast-paced while providing the 'receipts' for due diligence.
Frequently asked questions
- What is OneLeaf's primary product offering?
- OneLeaf offers personalized self-hypnosis audio programs delivered via a mobile app. The programs are designed to help users access their unconscious mind to address behavioral challenges like smoking, weight management, and anxiety, as described on Slides 4 and 6.
- How does OneLeaf plan to make money?
- According to Slide 9, the business model is a 'flywheel' that starts with either a one-time fee per specific program or an annual subscription. The goal is to convert single-program users into annual subscribers once they see results from their first session.
- Which markets did OneLeaf target for its initial launch?
- Slide 11 indicates that OneLeaf targeted the US market for its V1 launch in 2022. They specifically focused on two high-demand verticals: quitting smoking and weight loss, due to high search volume and low competition in the digital smoking cessation space.
- What scientific evidence does the deck provide for hypnosis?
- The deck cites multiple studies, including a 54% long-term relief rate for IBS patients (Slide 4) and a 68% decrease in hot flashes for breast cancer survivors (Slide 13). These metrics are used to frame hypnosis as a legitimate medical tool rather than just wellness.
- What are the key conversion metrics reported in the deck?
- On Slide 11, OneLeaf reports a 48% sign-up conversion rate and a 21% payment conversion rate within the first seven days of sign-up. These figures suggest strong initial product-market fit during their US testing phase.
